The phrase "adherence parameters" is correct and usable in written English.
It can be used in contexts where you are discussing the specific criteria or standards that need to be followed or maintained.
Example: "The study focused on the adherence parameters that determine the effectiveness of the treatment protocol."
Alternatives: "compliance criteria" or "conformity standards".
We also studied whether occurrence of an ILI in the intervention arm was associated with adherence parameters (such as duration of wearing a mask).
Participants were evaluated for standard clinical, virologic, immunologic, and adherence parameters at weeks 2 and 4 following enrollment (interrupted arms only, not included in outcome analysis) and every 6 weeks thereafter including toxicity monitoring (renal toxicity, ALT and AST were evaluated every 12 weeks and lipid profiles were done every 6 months).
Future studies should facilitate the development of appropriate adherence parameters in order to improve the reflection of the longitudinal aspect of adherence data.
The impact of the adherence parameter on model-simulated outcomes is typically explored via sensitivity analyses in which the level of adherence is varied systematically.
Electronic methods for compiling drug dosing histories are now the recognized standard for quantifying adherence, the parameters of which support model-based, continuous projections of drug actions and concentrations in plasma that are confirmable by intermittent, direct measurements at single time points.
Additionally other adherence related parameters and clinical questions were captured.
However, CPAP adherence and PSG parameters, such as AHI, 3 % ODI and arousal index, were similar between the groups.
Models have earlier also been developed to predict therapy outcome from virus genotype using clinical markers (viral load and CD4+ cell count), data on drug combinations in previously failed treatment regimens, and patient data (age, gender, mode of virus transmission, and adherence), as additional parameters in the modeling [15], [16].
Additionally, we will obtain time-varying covariates like socioeconomic parameters, adherence to treatment and information on QOL.
The costs of illness reflecting the difference in adherence and hospitalization parameters between the TDM+ and TDM− groups are shown in Figure 3.
Both GA and AA genotypes v. GG genotype were associated with a greater risk of hypertriacylglycerolaemia in adjusted analyses (GA: OR 1·23, 95 % CI 1·15, 1·33; AA: OR 1·47, 95 % CI 1·33, 1·62).> -wrap-foot> Table 4 demonstrates the joint results of genotype and MD adherence on metabolic parameters.
